Type 1 diabetes requires insulin therapy in the beginning. For patients with type 2 diabetes, most patients are initially treated with oral hypoglyceimic agents, but every available oral hypoglycaemic agent has limited glucose-lowering efficacy because of the progressive loss of pancreatic beta-cell function and decreased insulin sensitivity. Here, INS is linked to type 2 diabetes mellitus.